183 related articles for article (PubMed ID: 15658934)
21. Advanced Implantable Drug Delivery Systems via Continuous Manufacturing.
Maniruzzaman M; Nokhodchi A
Crit Rev Ther Drug Carrier Syst; 2016; 33(6):569-589. PubMed ID: 27992309
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in asymmetric membrane capsule based osmotic pump: a patent overview.
Patel A; Mehta T; Patel J; Patel M; Patel K; Patel N
Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):66-72. PubMed ID: 22191697
[TBL] [Abstract][Full Text] [Related]
23. Site specific chronotherapeutic drug delivery systems: a patent review.
Saigal N; Baboota S; Ahuja A; Ali J
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):64-70. PubMed ID: 19149730
[TBL] [Abstract][Full Text] [Related]
24. Osmotic drug delivery system as a part of modified release dosage form.
Keraliya RA; Patel C; Patel P; Keraliya V; Soni TG; Patel RC; Patel MM
ISRN Pharm; 2012; 2012():528079. PubMed ID: 22852100
[TBL] [Abstract][Full Text] [Related]
25. MEMS fabricated chip for an implantable drug delivery device.
Sbiaa Z
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5621-4. PubMed ID: 17947154
[TBL] [Abstract][Full Text] [Related]
26. Drug delivery systems. 4. Implants in drug delivery.
Ranade VV
J Clin Pharmacol; 1990 Oct; 30(10):871-89. PubMed ID: 2229447
[TBL] [Abstract][Full Text] [Related]
27. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
Song QL; Li P; Li YM
Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
[TBL] [Abstract][Full Text] [Related]
28. Novel Pump Control Technology Accelerates Drug Delivery Onset in a Model of Pediatric Drug Infusion.
Parker MJ; Lovich MA; Tsao AC; Deng H; Houle T; Peterfreund RA
Anesth Analg; 2017 Apr; 124(4):1129-1134. PubMed ID: 28181934
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical Technology Conference--12th International Meeting. Problems and problem solving strategies in pharmaceutical formulation and drug delivery. 12-15 September 2004, Istanbul, Turkey.
Steckel H
IDrugs; 2004 Nov; 7(11):996-9. PubMed ID: 15551172
[No Abstract] [Full Text] [Related]
30. Therapeutic applications of implantable drug delivery systems.
Dash AK; Cudworth GC
J Pharmacol Toxicol Methods; 1998 Jul; 40(1):1-12. PubMed ID: 9920528
[TBL] [Abstract][Full Text] [Related]
31. Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa.
Rastogi R; Teller RS; Mesquita PM; Herold BC; Kiser PF
Antiviral Res; 2013 Oct; 100(1):255-8. PubMed ID: 23973812
[TBL] [Abstract][Full Text] [Related]
32. Emerging technologies in solid drug delivery: an interview with Nadia Passerini.
Passerini N
Ther Deliv; 2017 Jan; 8(3):121-124. PubMed ID: 28145825
[TBL] [Abstract][Full Text] [Related]
33. 9th International drug delivery technologies & deal-making summit.
Panzner S; Smith PL
Expert Opin Drug Deliv; 2005 Jan; 2(1):189-90. PubMed ID: 16296745
[TBL] [Abstract][Full Text] [Related]
34. Microchips and controlled-release drug reservoirs.
Staples M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):400-17. PubMed ID: 20564466
[TBL] [Abstract][Full Text] [Related]
35. [A simulation design of a one-way micro valve for the micro engineering capsule].
Luo L; Zheng XL; Hou WS; Cui JG
Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Jul; 29(4):241-3. PubMed ID: 16268345
[TBL] [Abstract][Full Text] [Related]
36. Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.
Tian Z; Yu Q; Xie Y; Li F; Lu Y; Dong X; Zhao W; Qi J; Wu W
Pharm Res; 2016 Aug; 33(8):1988-97. PubMed ID: 27161487
[TBL] [Abstract][Full Text] [Related]
37. Natural and synthetic biomaterials for controlled drug delivery.
Kim JK; Kim HJ; Chung JY; Lee JH; Young SB; Kim YH
Arch Pharm Res; 2014 Jan; 37(1):60-8. PubMed ID: 24197492
[TBL] [Abstract][Full Text] [Related]
38. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
[TBL] [Abstract][Full Text] [Related]
39. Distribution of [3H]dexamethasone in rat subcutaneous tissue after delivery from osmotic pumps.
Moussy Y; Hersh L; Dungel P
Biotechnol Prog; 2006; 22(3):819-24. PubMed ID: 16739966
[TBL] [Abstract][Full Text] [Related]
40. [Osmotically controlled oral drug delivery systems: an update review].
Wang WP; Xie XQ; Yang DJ; Chen SL
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):598-602. PubMed ID: 18536389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
